Reversal of Neuromuscular Blockade in Diabetic Patients

NCT02057861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2014-02-07

No results posted yet for this study

Summary

In this study the investigators aimed to compare the time of antagonism and intensity of effect of sugammadex which is used for antagonism of rocuronium on diabetic and non-diabetic patients.

Conditions

  • Observation of Neuromuscular Block

Sponsors & Collaborators

  • Duzce University

    lead OTHER

Principal Investigators

  • yavuz demiraran, professor · Duzce University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-08-31
Completion
2013-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02057861 on ClinicalTrials.gov